Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nikolay Avxentyev
Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients With Metastatic Castration-Resistant Prostate Cancer
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
Related publications
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
Clinical Medicine Insights: Oncology
Oncology
Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients
Clinical Cancer Research
Cancer Research
Oncology
Cabazitaxel in the Management of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel-Based Chemotherapy
European Oncology and Haematology
Oncology
Hematology
Economic Evaluations of Cabazitaxel for Treatment of Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer: Evidence From a Systematic Review
Journal of Pharmaceutical Research International
Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
Clinical Concepts for Cabazitaxel in the Management of Metastatic Castration‐resistant Prostate Cancer
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients
Cancer Treatment and Research Communications
Cancer Research
Oncology
